Use of alpha-crystallin b (CRYAB) in the assessment of heart failure
A heart failure and multipurpose technology, applied in the field of CRYAB measurement kits, can solve the problems of insufficient labeling and low survival rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0041] In a first embodiment, the invention relates to a method of assessing heart failure in an individual comprising the steps of: a) measuring the concentration of the marker protein alpha-crystallin B (CRYAB) in a sample obtained from the individual; b) optionally, measuring the concentration of one or more other markers of heart failure in the sample; and c) by comparing the concentration determined in step (a) and optionally the concentration determined in step (b) with that determined in the control sample Established concentrations of this marker or these markers are compared to assess heart failure.
[0042] As used herein, each of the following terms has the meaning associated with it in this section.
[0043] The article "a" ("a" and "an") is used herein to refer to one or more than one (ie, at least one) of the grammatical object of an article. For example, "antibody" means one antibody or more than one antibody.
[0044] The expression "one or more" means 1 to 5...
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 